FGFBP2 anticorps (AA 121-220) (Cy7)

N° du produit ABIN1408248

Cet anticorps anti-FGFBP2 est un anticorps Lapin Polyclonal détectant FGFBP2 dans IF (cc) et IF (p). Adapté pour Humain.

Aperçu rapide pour FGFBP2 anticorps (AA 121-220) (Cy7) (ABIN1408248)

Antigène: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp FGFBP2 est conjugé à/à la Cy7

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Détail du produit anti-FGFBP2 anticorps (Cy7)

Épitope: AA 121-220

Réactivité croisée: Humain

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human FGFBP2/KSP37

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur FGFBP2

Antigène: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Autre désignation: FGFBP2/KSP37

Sujet:

Synonyms: FGF-binding protein 2, FGF-BP2, FGFBP-2, FGFBP2, FGFP2_HUMAN, Fibroblast growth factor-binding protein 2, HBp17-related protein, HBp17-RP, Ksp37, 37 kDa killer-specic secretory protein.

Background: KSP37 is a 223 amino acid protein that is secreted into the extracellular space and belongs to the fibroblast growth factor-binding protein family. Expressed in serum, as well as in cytotoxic T lymphocytes and peripheral leukocytes, KSP37 is thought to be involved in lymphocyte-mediated immunity, possibly playing a role in the development of asthma. The gene encoding KSP37 maps to human chromosome 4, which encodes nearly 6 % of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease.